Page 3«..2345..1020..»

Popular Fireworks Emit High Levels of Lead and Toxins – EcoWatch

§ July 7th, 2020 § Filed under Nano Medicine Comments Off on Popular Fireworks Emit High Levels of Lead and Toxins – EcoWatch

The Colima fir tree's distribution has been reduced to the area surrounding the Nevado de Colima volcano. In November 2019, Mexican authorities included the tree on a list of endangered species.

The Nevado de Colima volcano stands 4,260 meters (13,976 feet) above sea level. Agustn del Castillo

The fir forests are mainly located in the middle of slopes or in ravines. Agustn del Castillo

A tree and other vegetation in the cloud forest surrounding the Nevado de Colima volcano. Agustn del Castillo

A section of cloud forest in San Jos del Carmen, inside the state park created in 2009. Community members have been protecting the forest voluntarily for over two decades. Agustn del Castillo

An area of fir trees that has been destroyed by logging. Agustn del Castillo

The citizens of Huescalapa formed a cooperative to launch the El Alczar Ecotourism Center. El Alczar Ecotourism Center

Mara de la Luz Corts Reyes, the leader of the Amixtln cooperative, which was created in San Jos del Carmen. Agustn del Castillo

A view of the Nevado de Colima volcano from the Amixtln Ecotourism Center in San Jos del Carmen. Agustn del Castillo

Go here to read the rest:
Popular Fireworks Emit High Levels of Lead and Toxins - EcoWatch

Read the Rest...

The Role of Nanotechnology in a Forensic Investigation – AZoNano

§ July 7th, 2020 § Filed under Nanotechnology Comments Off on The Role of Nanotechnology in a Forensic Investigation – AZoNano

Image Credit:Alexandru-Radu Borzea/Shutterstock.com

It is evident that the application of nanoscience in a forensic investigation has helped criminologists to solve crime mysteries in less time and with greater efficiency. The rapid advancements in forensic science come with technological improvements in nanotechnology. This article highlights some of the major achievements in forensic science based on nanotechnology.

Fingerprints have been used as unique evidence by criminologists since ancient times. Latent fingerprints are developed from several colored materials such as aluminum flake on a dark background and carbon soot on a light background. However, these materials have major drawbacks such as unclear images of the fingerprint. This problem is solved by using nanotechnology-based materials.

The practice of latent fingerprint detection using nanoparticles can be traced back to 1970.

In 1980, gold and silver nanoparticles were commonly used for the visualization of latent fingerprints on the surface of porous paper. However, for the last 20 years, several other nanoparticles such as CdS (a photoluminescent nanocrystal capped with dioctysulfo-succinate), silicon dioxide, fluorescent starchbased carbon, Eu+3doped Al2O3, andaluminum oxide have been popularly used for the detection of latent fingerprints on both porous and nonporous surfaces.

More recently, a group of researchers found a novel ZnOSiO2 nano-powder for the detection of latent fingerprints on various surfaces (dry and wet). Thisnanopowder is highly efficient to envisage finger ridge in detail, which is an important factor for criminologists.

Read more on the equipment used in forensic applications.

The main reasons criminologists face major challenges in the detection of explosive residues are listed below:

The nano-based technology is immensely useful for the identification of the trace amount of fragmented explosives from the crime scene. This technology also helps the investigators to detect microscopic particles of gun powders on the shooters hand.

How are latent fingerprints developed using nanomaterials?

Curcumin nanoparticles and amine-terminated nanoparticles are highly sensitive and are effectively used for the detection of trinitrotoluene.

Nanotechnology also helps investigators to solve petroleum product problems, for example, in cases that involve arson and would require examination of petroleum hydrocarbon traces.

DNA (genetic material) is one of the most important and unique evidence that could identify the presence of a person at the scene of the crime.

Magnetic nanoparticles help extract DNA from different sources such as the skin, saliva, blood, semen, and hair.

Nanotechnology-based tools (carbon nanotube) also help to analyze DNA sequences using atomic force microscopy technique.

Trackers and barcodes are used to track down stolen or missing products. These barcodes help to prove the authenticity of an item and prevent duplicating or counterfeiting products of reputed brands.

Barcoding plays a significant role in keeping the brands reputation, and also prevents economic loss. Nanotechnology has developed various nanofibers and nanodots with color codes that could help detect fake products.

It is also extremely useful for maintaining prison security that prevents convicts from absconding. Nano trackers are injected into the prisoners body, enabling the duty officers to monitor the movement of a convict. Even after an individual is released, this tracker keeps a detailed footprint of their movement and has helped prevent subsequent crimes by the same criminal.

Nanotechnology is also relevant to solve cases related to cybercrime and sting operations (authentication of tapes and identification of speakers).

DFC is commonly known as date rape and involves psychotropic substances which impair the decision-making capacity or behavioral control of an individual.

These drugs are used in various criminal activities such as rape and other heinous sexual assault on all age groups (minors to adults). It is also used for money extortion and robbery.

While following the existing conventional methods for the detection of these kinds of drugs, forensic experts face a lot of challenges in terms of sensitivity, cost-effectiveness, and other instrumental limitations. Recently, researchers have developed a smart and efficient method for the identification of these illicit drugs with the help of nanotechnology.

This smart system uses citrate-stabilized gold nanoparticles (probe) and smartphone camera (analysis device) for quick qualitative and quantitative detection of codeine sulfate. This method is highly beneficial because of its ultra-sensitivity to detect a minute amount of codeine sulfate on-spot with great accuracy by analyzing the colorimetric changes in the probe.

Gold nanoparticles have also proved to be efficient for the detection of trace amounts of clonazepam.

Estimation of the exact time of death is a vital factor in crime investigation. In the conventional system, various parameters are analyzed to predict the time of death. Some of the important parameters are:

However, conventional methods can only predict an approximate time of death. Researchers believe that nanotechnology, i.e., fluorescent nanoparticles could be used to estimate the level of amino acids (VH) with the help of flow cytometry.

Prasand, V. et al. (2020) Role of nanomaterials for forensic investigation and latent fingerprinting- a review. Journal of Forensic Science. 65 (1), 26-36. https://doi.org/10.1111/1556-4029.14172

Pandya, A. and Shukla, R.K. (2018) New perspective of nanotechnology: role in preventive forensic.Egyptian Journal of Forensic Science.8,57. https://doi.org/10.1186/s41935-018-0088-0

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

Link:

The Role of Nanotechnology in a Forensic Investigation - AZoNano

Read the Rest...

7 Amazing Everyday Examples Of Nanotechnology In Action – Forbes

§ July 7th, 2020 § Filed under Nanotechnology Comments Off on 7 Amazing Everyday Examples Of Nanotechnology In Action – Forbes

Nanotechnology essentially means controlling matter on a tiny scale, at the atomic and molecular level. This sounds truly sci-fi, but can, in fact, be put to some very ordinary uses in surprisingly everyday products. In this article, well explore common products that make use of nanotechnology but first, lets get a quick overview of the amazing world of nanotechnology...

7 Amazing Everyday Examples Of Nanotechnology In Action

What is nanotechnology?

Nanotechnology is about looking at the world on such a tiny scale that we can not only see the atoms that make up everything around us (including ourselves), but we can manipulate and move those atoms around to create new things. Think of nanotechnology, then, as being a bit like construction only on a tiny scale.

And I do mean tiny. The nanoscale is 1,000 times smaller than the microscopic level and a billion times smaller than the typical world of meters that were used to measuring things in. (Nano literally means one-billionth.) If you took a human hair, for instance, it would measure approximately 100,000 nanometers wide. Thats the sort of scale were dealing with at a nano level.

Thats all very cool, I hear you say, but how does understanding this nanoscopic world impact (if youll excuse the pun) the world at large? For one thing, when we zoom in and look at materials on an atomic level, we sometimes find they behave quite differently and have completely different properties at the atomic level. As a simple example, silk feels incredibly soft and delicate to the touch, but if you look at it at a nano-level, youll see its made up of molecules aligned in cross-links, and this is what makes silk so strong. We can then use knowledge like this to manipulate other materials at a nano level, to create super-strong, state-of-the-art materials like Kevlar.

This is where the technology bit of nanotechnology comes in using our knowledge of materials at a nano-level to create exciting new solutions and products.

Everyday products that use nanotechnology

Nanotechnology may seem like something out of the future, but in fact, many everyday products are already made using nanotechnology. Take these seven common products, for instance:

1. Sunscreen

Nanoparticles have been added to sunscreens for years to make them more effective. Two particular types of nanoparticles commonly added to sunscreen are titanium dioxide and zinc oxide. These tiny particles are not only highly effective at blocking UV radiation, they also feel lighter on the skin, which is why modern sunscreens are nowhere near as thick and gloopy as the sunscreens we were slathered in as kids.

2. Clothing

When used in textiles, nanoparticles of silica can help to create fabrics that repel water and other liquids. Silica can be added to fabrics either by being incorporated into the fabrics weave or sprayed onto the surface of the fabric to create a waterproof or stainproof coating. So if youve ever noticed how liquid forms little beads on waterproof clothing beads that simply roll off the fabric rather than being absorbed thats thanks to nanotechnology.

3. Furniture

In the same way that clothing can be made waterproof and stainproof through nanotechnology, so too can upholstered furniture. Even better, nanotechnology is also helping to make furniture less flammable; by coating the foam used in upholstered furniture with carbon nanofibers, manufacturers can reduce flammability by up to 35 percent.

4. Adhesives

Nanotechnology can also be used to optimize adhesives. Interestingly, most glues lose their stickiness at high temperatures, but a powerful nano-glue not only withstands high temperatures it gets stronger as the surrounding temperature increases.

5. Coatings for car paintwork

We all know bird droppings can wreak havoc on car paintwork. To combat this, a company called Nanorepel has produced a high-performance nanocoating that can be used to protect your cars paintwork from bird poop. The company also makes coatings to protect car upholstery from stains and spillages.

6. Tennis balls

Nanotechnology has found a range of applications in the world of sports equipment, with a couple of great examples coming from one of my favorite sports: tennis. Nanotechnology helps tennis balls keep their bounce for longer, and make tennis racquets stronger.

7. Computers

Without nanotechnology, we wouldn't have many of the electronics we use in everyday life. Intel is undoubtedly a leader in tiny computer processors, and the latest generation of Intels Core processor technology is a 10-nanometer chip. When you think a nanometer is one-billionth of a meter, thats incredibly impressive!

Nanotechnology is just one of 25 technology trends that I believe will transform our society. Read more about these key trends including plenty of real-world examples in my new book, Tech Trends in Practice: The 25 Technologies That Are Driving The 4th Industrial Revolution.

Read the original post:

7 Amazing Everyday Examples Of Nanotechnology In Action - Forbes

Read the Rest...

Potential Impact of COVID-19 on Research report explores the Healthcare Nanotechnology (Nanomedicine) Market for the forecast period, 2020-2026 -…

§ July 7th, 2020 § Filed under Nanotechnology Comments Off on Potential Impact of COVID-19 on Research report explores the Healthcare Nanotechnology (Nanomedicine) Market for the forecast period, 2020-2026 -…

Healthcare Nanotechnology (Nanomedicine) Marketreport provides in-depth COVID19 impact analysis ofMarket Overview, Product Scope, Market Drivers, Trends, Opportunities,Market Driving Force and Market Risks. It also profile the topmost prime manufacturers (Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith&Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Shire, Ipsen, Endo International) are analyzed emphatically by competitive landscape contrast, with respect toPrice, Sales,Capacity, Import, Export, Consumption, Gross, Gross Margin, Revenue and Market Share. Healthcare Nanotechnology (Nanomedicine) industry breakdown data are shown at the regional level, to show the sales, revenue and growth by regions.Healthcare Nanotechnology (Nanomedicine) Market describe Healthcare Nanotechnology (Nanomedicine) Sales Channel,Distributors, Customers, Research Findings and Conclusion, Appendix and Data Source.

Key Target Audience of Healthcare Nanotechnology (Nanomedicine) Market:Manufacturers of Healthcare Nanotechnology (Nanomedicine), Raw material suppliers, Market research and consulting firms, Government bodies such as regulating authorities and policy makers, Organizations, forums and alliances related to Healthcare Nanotechnology (Nanomedicine) market.

Get Free Sample PDF (including full TOC, Tables and Figures)of Healthcare Nanotechnology (Nanomedicine)[emailprotected]https://www.researchmoz.us/enquiry.php?type=S&repid=2041239

In-Depth Qualitative Analyses Include Identification and Investigation Of The Following Aspects:Healthcare Nanotechnology (Nanomedicine) Market Structure, Growth Drivers, Restraints and Challenges, Emerging Product Trends & Market Opportunities, Porters Fiver Forces.

Summary of Healthcare Nanotechnology (Nanomedicine) Market:It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.

Nanotechnology is becoming a crucial driving force behind innovation in medicine and healthcare, with a range of advances including nanoscale therapeutics, biosensors, implantable devices, drug delivery systems, and imaging technologies.

The classification of Healthcare Nanotechnology includes Nanomedicine, Nano Medical Devices, Nano Diagnosis and Other product. And the sales proportion of Nanomedicine in 2017 is about 86.5%, and the proportion is in increasing trend from 2013 to 2017.

On the basis on the end users/applications,this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Healthcare Nanotechnology (Nanomedicine) market foreach application, including-

Anticancer CNS Product Anti-infective Other

On the basis of product,this report displays the sales volume, revenue (Million USD), product price, market share and growth rate ofeach type, primarily split into-

Nanomedicine Nano Medical Devices Nano Diagnosis Other

Do You Have Any Query Or Specific Requirement? Ask to Our Industry[emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid=2041239

Important Healthcare Nanotechnology (Nanomedicine) Market Data Available In This Report:

Contact:

ResearchMoz Mr. Rohit Bhisey, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email:[emailprotected]

Browse More Reports Visit @https://bit.ly/2Sepby2

The rest is here:

Potential Impact of COVID-19 on Research report explores the Healthcare Nanotechnology (Nanomedicine) Market for the forecast period, 2020-2026 -...

Read the Rest...

Nanotechnology patents: challenge for industrial property and its regulations – Lexology

§ July 7th, 2020 § Filed under Nanotechnology Comments Off on Nanotechnology patents: challenge for industrial property and its regulations – Lexology

Patents usually make it possible to measure the results of the incorporation of new technologies in society. In the case of nanotechnology, it has given rise to a huge number of potentially innovative ideas, however, as in many other cases, technology advances faster than the legal framework that covers it

The US National Institute for Human Genome Research defines nanotechnology as a science where various elements are manipulated at the atomic scale in order to solve difficult problems to solve on larger scales. This developing science has useful applications in different areas of scientific interest, for example: in the environment to facilitate water desalination or soil decontamination, in renewable energies to improve its production and storage, in medicine for the development of drug nanotransporters to specific unreachable parts of the body, etc.

According to Conacyt (National Council of Science and Technology), Mexico ranks second in Latin America in the ranking of the countries with the largest initiatives, research projects, infrastructure, and the number of nanotechnology publications. Various reports indicate that more than 56 institutions and 159 national laboratories are dedicated solely to the research and dissemination of this science. The growth in productivity, development and investment in this field forces the industrial property area to ask questions regarding the registration of these new technologies. Like any other science that was once in development and challenged the paradigms of industrial property to make changes to its laws and processes, the nanotechnology registry is already beginning to raise questions to industrial property.

According to the World Industrial Property Organization (WIPO), one of the most important questions has to do with the size of the technology that will be registered. For example, if there is a very similar technique at larger levels, such as the atomic level, would it be valid to record the nanometric technique? If not, how would scientific institutions protect their nanometric technologies that differ in efficiency and results with processes? existing at larger levels? Another important aspect to consider is whether the current terms, such as nanoscale, that are used in patents are the specific ones to distinguish one technology from another.

Nanotechnology is probably forcing us to be more specific in the use and registration of these processes, otherwise the claims of a patent application could be confusing and vague for the creators of these technologies. While it is true that nanotechnology is a new field and therefore it can be argued that there is not a sufficient state of the art to comply with the legal framework of industrial property, WIPO is already working to see what arrangements are in place for the current legislation on patents can help address these new challenges. It is of utmost importance for the industrial property sector to anticipate these challenges that come with nanotechnology and its registration, to avoid difficult legal conflicts to resolve.

That being said, not only the definition nanoscale brings ambiguity, words like nanotechnology and nano-agglomerates also bring with them a certain level of uncertainty as many corporations in the industrial property sector use them differently, making it impossible to create uniformity. and consensus regarding the use of these words. According to WIPO, this lack of standard definitions can have a significant impact on the classification of patents and on the monitoring of its evolution. In worse cases, this inconsistency may cast doubt on the patentability of technologies, since if we consider that one of the patentability criteria is that of inventive step, which establishes that the invention must not be evident from the state of the art for an expert in the matter, the criteria could not be valid since it could be argued that the terms such as on a nanometric scale are sufficiently ambiguous so that the person skilled in the art can interpret it without uncertainty and therefore validly rule whether the inventive step is fulfilled or not.

To avoid these potential problems, the United States Patent and Trademark Office (USPTO), the European Patent Office (EPO), and the Japan Patent Office (JPO), which are the main offices that register nanotechnology patents currently, they have decided that any invention of nanotechnology must operate on a scale less than 100 nanometers. Thus, patent applications submitting measurements with different nanometer arrangements are excluded. This consensus of the most important worldwide patent offices in this matter makes it possible to give uniformity and structure to the nanotechnology patent applications registry.

As mentioned at the beginning of the article, nanotechnology has various applications across very different fields from each other. This feature of the field is beneficial because for the diversity of processes that it can help; however, it can be a problem for industrial property experts. Typically, patent applications are assigned to experts in the field to determine their patentability by evaluating the invention. However, this is not feasible in the field of nanotechnology due to the wide range of areas that its inventions can cover. WIPO states that it is unlikely that a single expert can adequately assess whether or not the application meets the patentability criteria.

Beyond the fact that patent offices need to spend more monetary and human resources to evaluate such applications for the simple fact that more experts in the field will be required to review the patentability of an application, the problem of multidisciplinary can make that the risk of improperly evaluating the pertinent state of the art or inventive step increases, since the application evaluators may not be exactly experts in the matter; for example, pharmacology experts may evaluate nanotechnology applications that have to do with distributing drugs in specific parts of the body, however, experts may not necessarily have the necessary experience to rigorously evaluate a pharmacological invention related to nanotechnology. This problem can be aggravated later when patents that do not meet the standard are granted and later canceled in court.

Problems with nanotechnology in the field of industrial property increase when nanotechnology inventions contain similar formulations of previously disclosed and patented structures, compounds, and materials. The most controversial example of this problem was the BASF case against Orica Australia, where it was disputed that previously registered BASF polymer nanoparticles of more than 111 nanometers nullified the novelty of particles less than 100 nanometers that Orica was trying to patent. The courts of the EPO, however, determined that the Orica particles were novel since they presented improved properties such as the brightness of their surface. This difference was considered sufficient to validate its novelty. This case invites us to reflect on the complications of deciding whether or not a patent application is novel to nanoscales. Firstly, the difference in size of the different techniques has never been enough to say that they are both novel. Then, we must remember that in the history of intellectual property, the slightest coincidence with previous techniques may be enough to nullify the novelty character of an application. Considering these implications, we can see how nanotechnology is already beginning to challenge the criteria established in industrial property.

When drafting the claims of a patent related to nanotechnology, the technical and legal variables that help ensure a good probability of granting should be considered, especially taking into account that different Patent Offices worldwide interpret the principles that govern the law of patents in different ways, which can affect the patentability of an invention.

Specifically, and in the case of Mexico, when processing and defending patent applications from this technological branch, it is advisable to treat and negotiate the respective objections of the examiners before the Mexican Institute of Industrial Property (IMPI), always striving to achieve multidisciplinary interviews with all the examiners, thus achieving, convening and bringing together examiners from various areas of technical knowledge, in order to achieve a comprehensive and clear understanding of the entire invention in question, which will help to address the objections issued from various technological fronts, thus achieving an agile grant and that includes the main novel and inventive characteristics of the corresponding patent application.

One of the tasks for the future, for all actors involved in and related to nanotechnology, will be to encourage and foster sustained and continuous innovation in nanotechnology, ensuring that the associated intellectual property system grants certain, consistent and broad freedom to innovators. so that they can work and develop new nanotechnological applications, avoiding at all costs any problem, technical or legal, that affects the incentives for the disclosure of patents, investment in them and at the same time creating a legal environment that helps the holders to promote litigation cases that weigh and cover all the technical aspects associated with each case.

The cycle of science revolution occurs when established and evidence-based paradigms begin to be challenged and refuted by new technologies. Later, science goes through a stage of uncertainty in which scientists and experts in the field seek the new paradigm to guide their research and discoveries. In the end, the revolution is consolidated when new paradigms are found and adopted by scientists. In the same way, industrial property seems to have entered this cycle of revolution in science. While it is true that industrial property laws cannot be fully rebutted, uncertainty is already beginning to be found in the way of processing, evaluating, and handling applications and patents related to nanotechnology. Following the course of the cycle, it would be prudent to wait for the new modifications that the intellectual property organizations will make to their respective laws in order to give stability to the experts of the field in the way of processing and patenting the nanotechnology techniques.

See the original post here:

Nanotechnology patents: challenge for industrial property and its regulations - Lexology

Read the Rest...

Healthcare Nanotechnology (Nanomedicine) Market Is Set a Rapid Growth Expected to Reach USD Billion with CAGR of +12% During 2020-2027: Abbott…

§ July 7th, 2020 § Filed under Nanotechnology Comments Off on Healthcare Nanotechnology (Nanomedicine) Market Is Set a Rapid Growth Expected to Reach USD Billion with CAGR of +12% During 2020-2027: Abbott…

The report titled, Healthcare Nanotechnology (Nanomedicine) Market boons an in-depth synopsis of the competitive landscape of the market globally, thus helping establishments understand the primary threats and prospects that vendors in the market are dealt with. It also incorporates thorough business profiles of some of the prime vendors in the market. The report includes vast data relating to the recent discovery and technological expansions perceived in the market, wide-ranging with an examination of the impact of these intrusions on the markets future development.

Healthcare Nanotechnology (Nanomedicine) Market research reports growth rates and the market value based on market dynamics, growth factors. The complete knowledge is based on the latest innovations in the industry, opportunities, and trends. In addition to SWOT analysis by key suppliers, the report contains a comprehensive market analysis and major players landscape.

Ask for Sample Copy of This Report: https://www.healthcareintelligencemarkets.com/request_sample.php?id=113359

Top Key Players Included in This Report:

Major highlights of this research report:

The report on the Healthcare Nanotechnology (Nanomedicine) Market has newly added by IT Intelligence Markets to its huge repository. The global market is expected to increase from 2020 to 2027. Primary and secondary research methodologies have been used for curating this research report.

Get Discount on This Report: https://www.healthcareintelligencemarkets.com/ask_for_discount.php?id=113359

The competitive landscape of the Healthcare Nanotechnology (Nanomedicine) Market is described in terms of the players and their statistics. For each key player, the report reveals production rates, costing, overall pricing, revenue generation, and market share within the Healthcare Nanotechnology (Nanomedicine) Market.

Finally, all aspects of the global Healthcare Nanotechnology (Nanomedicine) Market are quantitatively as well qualitatively assessed to study the global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and its future prospects.

Table of Contents

Global Healthcare Nanotechnology (Nanomedicine) Market Research Report

Chapter 1 Healthcare Nanotechnology (Nanomedicine) Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Continue TOC

*If you have any special requirements, please let us know and we will offer you the report as per your requirements.

For Any Customization, Ask Our Experts: https://www.healthcareintelligencemarkets.com/enquiry_before_buying.php?id=113359

About Us:

HealthCare Intelligence Markets Reports provides market intelligence & consulting services to a global clientele spread over 145 countries. Being a B2B firm, we help businesses to meet the challenges of an ever evolving market with unbridled confidence. We craft customized and syndicated market research reports that help market players to build game changing strategies. Besides, we also provide upcoming trends & future market prospects in our reports pertaining to Drug development, Clinical & healthcare industries. Our intelligence enables our clients to take decisions with which in turn proves a game-changer for them. We constantly strive to serve our clients better by directly allowing them sessions with our research analysts so the report is at par with their expectations.

Contact Us:

Marvella Lit

Address: 90, State Office Center,

90, State Street Suite 700,

Albany, NY 12207

Email: [emailprotected]

Web: http://www.healthcareintelligencemarkets.com

Phone: +44-753-712-1342

More here:

Healthcare Nanotechnology (Nanomedicine) Market Is Set a Rapid Growth Expected to Reach USD Billion with CAGR of +12% During 2020-2027: Abbott...

Read the Rest...

Nanotechnology in Medical Market Growth By Manufacturers, Type And Application, Forecast To 2026 – 3rd Watch News

§ July 7th, 2020 § Filed under Nanotechnology Comments Off on Nanotechnology in Medical Market Growth By Manufacturers, Type And Application, Forecast To 2026 – 3rd Watch News

Others

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=306423&utm_source=3WN&utm_medium=888

The Nanotechnology in Medical market report provides successfully marked contemplated policy changes, favorable circumstances, industry news, developments, and trends. This information can help readers fortify their market position. It packs various parts of information gathered from secondary sources, including press releases, web, magazines, and journals as numbers, tables, pie-charts, and graphs. The information is verified and validated through primary interviews and questionnaires. The data on growth and trends focuses on new technologies, market capacities, raw materials, CAPEX cycle, and the dynamic structure of the Nanotechnology in Medical market.

This study analyzes the growth of Nanotechnology in Medical based on the present, past and futuristic data and will render complete information about the Nanotechnology in Medical industry to the market-leading industry players that will guide the direction of the Nanotechnology in Medical market through the forecast period. All of these players are analyzed in detail so as to get details concerning their recent announcements and partnerships, product/services, and investment strategies, among others.

Sales Forecast:

The report contains historical revenue and volume that backing information about the market capacity, and it helps to evaluate conjecture numbers for key areas in the Nanotechnology in Medical market. Additionally, it includes a share of each segment of the Nanotechnology in Medical market, giving methodical information about types and applications of the market.

Reasons for Buying Nanotechnology in Medical Market Report

This report gives a forward-looking prospect of various factors driving or restraining market growth.

It renders an in-depth analysis for changing competitive dynamics.

It presents a detailed analysis of changing competition dynamics and puts you ahead of competitors.

It gives a six-year forecast evaluated on the basis of how the market is predicted to grow.

It assists in making informed business decisions by performing a pin-point analysis of market segments and by having complete insights of the Nanotechnology in Medical market.

This report helps the readers understand key product segments and their future.

Have Any Query? Ask Our Expert @ https://www.marketresearchintellect.com/need-customization/?rid=306423&utm_source=3WN&utm_medium=888

In the end, the Nanotechnology in Medical market is analyzed for revenue, sales, price, and gross margin. These points are examined for companies, types, applications, and regions.

To summarize, the global Nanotechnology in Medical market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Gene Panel Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Body Wash and Shower Gel Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Blood Glucose Monitoring Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Bisoprolol Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Bitterness Suppressors and Flavor Carriers Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Follow this link:

Nanotechnology in Medical Market Growth By Manufacturers, Type And Application, Forecast To 2026 - 3rd Watch News

Read the Rest...

Nanotechnology Drug Delivery Competitive Market Growth By Manufacturers, Type And Application, Forecast To 2026 – 3rd Watch News

§ July 7th, 2020 § Filed under Nanotechnology Comments Off on Nanotechnology Drug Delivery Competitive Market Growth By Manufacturers, Type And Application, Forecast To 2026 – 3rd Watch News

Others

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=235719&utm_source=3WN&utm_medium=888

The Nanotechnology Drug Delivery Competitive market report provides successfully marked contemplated policy changes, favorable circumstances, industry news, developments, and trends. This information can help readers fortify their market position. It packs various parts of information gathered from secondary sources, including press releases, web, magazines, and journals as numbers, tables, pie-charts, and graphs. The information is verified and validated through primary interviews and questionnaires. The data on growth and trends focuses on new technologies, market capacities, raw materials, CAPEX cycle, and the dynamic structure of the Nanotechnology Drug Delivery Competitive market.

This study analyzes the growth of Nanotechnology Drug Delivery Competitive based on the present, past and futuristic data and will render complete information about the Nanotechnology Drug Delivery Competitive industry to the market-leading industry players that will guide the direction of the Nanotechnology Drug Delivery Competitive market through the forecast period. All of these players are analyzed in detail so as to get details concerning their recent announcements and partnerships, product/services, and investment strategies, among others.

Sales Forecast:

The report contains historical revenue and volume that backing information about the market capacity, and it helps to evaluate conjecture numbers for key areas in the Nanotechnology Drug Delivery Competitive market. Additionally, it includes a share of each segment of the Nanotechnology Drug Delivery Competitive market, giving methodical information about types and applications of the market.

Reasons for Buying Nanotechnology Drug Delivery Competitive Market Report

This report gives a forward-looking prospect of various factors driving or restraining market growth.

It renders an in-depth analysis for changing competitive dynamics.

It presents a detailed analysis of changing competition dynamics and puts you ahead of competitors.

It gives a six-year forecast evaluated on the basis of how the market is predicted to grow.

It assists in making informed business decisions by performing a pin-point analysis of market segments and by having complete insights of the Nanotechnology Drug Delivery Competitive market.

This report helps the readers understand key product segments and their future.

Have Any Query? Ask Our Expert @ https://www.marketresearchintellect.com/need-customization/?rid=235719&utm_source=3WN&utm_medium=888

In the end, the Nanotechnology Drug Delivery Competitive market is analyzed for revenue, sales, price, and gross margin. These points are examined for companies, types, applications, and regions.

To summarize, the global Nanotechnology Drug Delivery Competitive market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Textile Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Peritoneal Dialysis Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Animal Wound Care Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Automotive battery Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Automotive Electronic Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Read more from the original source:

Nanotechnology Drug Delivery Competitive Market Growth By Manufacturers, Type And Application, Forecast To 2026 - 3rd Watch News

Read the Rest...

Leading Public Health Experts to Oversee Development of Enhanced Cruise Line Health and Safety Standards – PR Newswire UK

§ July 6th, 2020 § Filed under Quantum Medicine Comments Off on Leading Public Health Experts to Oversee Development of Enhanced Cruise Line Health and Safety Standards – PR Newswire UK

"Healthy Sail Panel" comprises top experts in public health, infectious disease, biosecurity, hospitality and maritime operations

MIAMI, July 6, 2020 /PRNewswire/ -- Cruise industry leaders Royal Caribbean Group (NYSE: RCL) and Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) announced a collaboration to develop enhanced cruise health and safety standards in response to the global COVID-19 pandemic. The companies have asked Governor Mike Leavitt and Dr. Scott Gottlieb to serve as co-chairs of a newly formed group of experts called the "Healthy Sail Panel." The panel is tasked with collaboratively developing recommendations for cruise lines to advance their public health response to COVID-19, improve safety, and achieve readiness for the safe resumption of operations.

The expert panel has been working for nearly a month and will offer its initial recommendations by the end of August.The cruise lines said its work will be "open source," and could be freely adopted by any company or industry that would benefit from the group's scientific and medical insights.

"This unprecedented disease requires us to develop unprecedented standards in health and safety," said Richard D. Fain, chairman and CEO of Royal Caribbean Group. "Bringing aboard these respected experts to guide us forward demonstrates our commitment to protecting our guests, our crews and the communities we visit."

"We compete for the vacationing consumer's business every day, but we never compete on health and safety standards," said Frank Del Rio, president and CEO of Norwegian Cruise Line Holdings Ltd. "While the cruise industry has always had rigorous health standards, the unique challenges posed by COVID-19 provide an opportunity to raise the bar even higher."

"Health and safety are the highest priority for all CLIA cruise line members as demonstrated by this initiative on the part of two of our largest members. We commend this and parallel efforts of all of our members, large and small, who are working tirelessly to develop appropriate protocols based on input from health authorities and medical experts in the U.S. and abroad," said Kelly Craighead, president and CEO of Cruise Lines International Association (CLIA).

Fain and Del Rio said they initiated the panel to assure the plans they will submit to the U.S. Centers for Disease Control and Prevention (CDC) and other regulators apply the best available public health, science and engineering insights. The work of the panel will be shared with the entire industry and regulators.

"In convening the Healthy Sail Panel, we sought the participation of a diverse group of leading experts in areas of science and public health that are directly relevant to the considerations listed by the No Sail Order," said Governor Leavitt. "We view our work as a profoundly important public health effort. The health and safety of passengers, crew, and the communities that cruise ships visit will be the principal focus of this project."

Dr. Gottlieb said, "We know that the public health issues that must be addressed are complex, and in some areas, tackling them will require novel approaches. Our goal in assembling this team of leading experts was to develop best practices that can improve safety and provide a roadmap for reducing the risks of COVID-19."

The panel is co-chaired by Governor Leavitt, former Secretary of the U.S. Department Health and Human Services (HHS), and Dr. Scott Gottlieb, former commissioner of the U.S. Food and Drug Administration (FDA). The panel's members are globally recognized experts from various disciplines, including public health, infectious disease, biosecurity, hospitality and maritime operations.

The members of the expert panel are:

Governor Mike Leavitt Mike Leavitt was a three term Governor of Utah and served as Administrator of the EPA and Secretary of HHS under President George W. Bush. He is the founder of Leavitt Partners, a firm that provides investment support, data and analytics, member-based alliances, and direct services to clients to support decision-making strategies in the value economy.

Dr. Scott Gottlieb Dr. Scott Gottlieb was the Commissioner of the FDA from 2017-2019 and served as the agency's Deputy Commissioner for Medical and Scientific Affairs from 2005-2007. He is a physician trained in internal medicine and is currently a resident fellow at the American Enterprise Institute.

Helene Gayle M.D., MPH Dr. Gayle is CEO of the Chicago Community Trust, one of the nation's leading community foundations. Prior to this role, foralmost a decade, she was president and CEO of CARE, a leading international humanitarian organization. An expert on global development, humanitarian and health issues, Dr. Gayle spent 20 years with the CDC, working primarily on HIV/AIDS. She worked at the Bill & Melinda Gates Foundation, directing programs on HIV/AIDS and other global health issues. She also launched the McKinsey Social Initiative (now McKinsey.org), a nonprofit that builds partnerships for social impact. Dr. Gayle serves on public company and nonprofit boards, including The Coca-Cola Company, Colgate-Palmolive Company, the Brookings Institution, the Center for Strategic and International Studies, New America, the ONE Campaign, the Federal Reserve Bank of Chicago and the Economic Club of Chicago. She is a member of the Council on Foreign Relations, the American Public Health Association, the National Academy of Medicine, the National Medical Association and the American Academy of Pediatrics.

Julie Gerberding, M.D., MPH Dr. Julie L. Gerberding is Executive Vice President and Chief Patient Officer for Merck, leading all aspects of strategic communications, global public policy, population health and patient engagement.

A former head of the CDC and a world-renowned public health expert, Dr. Gerberding is deeply committed to achieving sustainable global health impact and tackling some of the most challenging health priorities of our time. This includes addressing critical issues such as affordable access to important therapies, advocating for health policies that promote and sustain innovation of new medicines and vaccines, and improving maternal mortality through the Merck for Mothers program a public-private partnership helping to meet the United Nations' Sustainable Development Goal to reduce maternal mortality.

Prior to joining Merck, Dr. Gerberding served as the Director of the CDC from 2002-2009 and was the first female to hold that position. While at the agency, she led more than 40 emergency responses against crises such as anthrax, SARS, bird flu, food-borne outbreaks and natural disasters. Previously, Dr. Gerberding was a tenured faculty member in Infectious Diseases at the University of California at San Francisco (UCSF). She continues as an Adjunct Associate Clinical Professor of Medicine at UCSF.

Steven Hinrichs, M.D. Dr. Steven Hinrichs is Professor and Chair in the Department of Pathology and Microbiology at the University of Nebraska Medical Center in Omaha and the Director of the Nebraska Public Health Laboratory (NPHL), and Director of the University of Nebraska Center for Biosecurity. In his position as laboratory director he has been responsible for the development of a statewide program for the rapid identification of biological agents of mass destruction. He is principal investigator of multiple national awards from the Association of Public Health Laboratories (APHL) and the CDC and the U.S. Department of Defense for the development of an outreach program to extend training and expertise in the early recognition of biological warfare agents. Dr. Hinrichs received his M.D. from the University of North Dakota and is board certified in Anatomical and Clinical Pathology. His research laboratory focuses on molecular diagnostics and the role of viruses in cancer. Dr. Hinrichs has published over 130 papers in basic science and medical journals.

Michael Osterholm, M.D., Ph.DMichael Osterholm is one of the nation's foremost experts in public health, infectious disease and biosecurity. As the director of the Center for Infectious Disease Research and Policy at the University of Minnesota, he is an international leader on the world's preparedness for pandemics. He has led numerous investigations into internationally important disease outbreaks, including foodborne diseases, hepatitis B in health care settings, and HIV infection in healthcare workers, and he is a frequent consultant to the World Health Organization, the National Institutes of Health, the FDA, the U.S. Department of Defense and the CDC. From 2001 to 2005, Dr. Osterholm served as a special advisor to the Secretary of HHS on issues related to bioterrorism and public health preparedness. From June 2018 through May 2019, he served as a Science Envoy for Health Security on behalf of the U.S. Department of State. He has also been appointed to the National Science Advisory Board on Biosecurity and the World Economic Forum's Working Group on Pandemics, among other prominent advisory positions.

Stephen Ostroff, M.D.Dr. Ostroff brings years of experience in public health, having served at high level positions at the FDA and CDC. He was the Acting Commissioner of the FDA from 2015-2016, and before that served as the FDA's chief scientist. Ostroff joined the FDA in 2013 as chief medical officer in the Center for Food Safety and Applied Nutrition and senior public health advisor to FDA's Office of Foods and Veterinary Medicine. Prior to that he served as deputy director of the National Center for Infectious Diseases at the CDC, where he was also acting director of CDC's Select Agent Program. While at the CDC he focused on emerging infectious diseases, food safety, and coordination of complex outbreak response. He retired from the Commissioned Corps of the U.S. Public Health Service at the rank of Rear Admiral (Assistant Surgeon General). Ostroff was also the director of the Bureau of Epidemiology and acting physician general for the Commonwealth of Pennsylvania and has consulted internationally on public health projects in South Asia and Latin America. Ostroff graduated from the University of Pennsylvania School of Medicine in 1981 and completed residencies in internal medicine at the University of Colorado Health Sciences Center and preventive medicine at CDC.

William Rutala, Ph.D, M.S., MPH Dr. Rutala has experience medically managing a variety of diseases and extensive experience studying epidemiology and virology, particularly managing outbreaks and emerging pathogens.Dr. Rutala's research interests are the etiology and prevention of healthcare-associated infections with a special focus on disinfection and sterilization of reusable medical and surgical devices (e.g., endoscopes, surgical instruments). Other areas of active research include contribution of the hospital environment to disease transmission, hand hygiene, preventing transmission of infectious agents, including multiply-drug resistant organisms, prevention of healthcare-associated Creutzfeldt-Jakob Disease, investigation of healthcare-associated outbreaks, and new and emerging pathogens in healthcare.

Kate Walsh, Ph.DKate Walsh is the Dean at the School of Hotel Administration at Cornell University and E.M. Statler Professor. A professor of management, she is a leader in education for the global hospitality industry; and a renowned expert in organizational service design, leadership and career development, as well as the impact of strategic human capital investments. In addition to authoring and contributing to books, Dr. Walsh's articles have appeared in numerous research outlets. She has over 20 years of academic experience, including in her current role as dean.

In addition, Dean Walsh holds extensive industry knowledge from serving as the former director of training and development for Nikko Hotels International, corporate training manager for the former Bristol Hotels, and senior auditor for Loews Corporation. She is also a former New York State Certified Public Accountant. Since the beginning of her administration as dean, Dean Walsh has focused on positioning the school for the future of education. This includes undertaking a comprehensive renewal of the graduate and undergraduate curricula, developing the school's online global presence, identifying international partners for master-level program development, and providing thought leadership for the hospitality industry, most notably through the creation of industry research partnerships for faculty, fostering new initiatives through the school's six centers and institutes, and providing faculty-developed resources to guide the industry. Dr. Walsh received her Ph.D. from the Carroll School of Management at Boston College and her M.P.S. degree from Cornell's School of Hotel Administration.

Captain Patrik DahlgrenCaptain Patrik Dahlgren is the Senior Vice President of Global Marine Operations and Fleet Optimization for all Royal Caribbean Groupglobal brands. Dahlgren's seagoing experiences started as a bridge officer aboard tugboats, yachts and an array of cargo vessels and ferries. He rose through the ranks with over 15 years onboard Royal Caribbean International cruise ships, with his last seagoing command as Master of Oasis of the Seas and Quantum of the Seas. He was a lead contributor to the Quantum of the Seas development and received the esteemed RINA (Royal Institute of Naval Architects) award for its innovation and contributions to maritime safety.

Robin LindsayRobin Lindsay is the Executive Vice President of Vessel Operations for Norwegian Cruise Line Holdings Ltd. Lindsay was appointed to this position in January 2015. In this role, Lindsay is responsible for Marine & Technical Operations, Hotel Operations, Entertainment, Product Development, Port & Destination Services, Fleet Personnel, Out Islands and New Build & Ship Refurbishment for all three of the company's brands Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises.

Prior to joining Norwegian Cruise Line Holdings Ltd., Lindsay served in a similar capacity as Executive Vice President of Vessel Operations at Prestige Cruise Holdings, the parent company of Oceania Cruises and Regent Seven Seas Cruises. Lindsay's history with the company goes back to the inception of Oceania Cruises in 2003, where he joined as Senior Vice President, Hotel Operations and Vessel Operations. Lindsay earned his B.S. degree from Louisiana Tech University.

In addition, several experts will also serve as senior advisors to the panel, including Dr. Caitlin Rivers, who is a faculty member and epidemiologist at the Johns Hopkins Bloomberg School of Public Health and an expert in emerging infectious disease epidemiology and outbreak science, and Dr. Phyllis Kozarsky, who is a professor emerita of medicine in the Division of Infectious Diseases at Emory University School of Medicine and an expert in pre-travel health advice and education, global health, and the epidemiology of travel related infections and infectious diseases. Dr. Kozarsky serves as an expert consultant to the Division of Global Migration and Quarantine in travelers' health with the CDC.

More assets available here:

About Royal Caribbean GroupRoyal Caribbean Group (NYSE: RCL) is a global cruise vacation company that controls and operates four global brands: Royal Caribbean International, Celebrity Cruises, Azamara and Silversea Cruises. The Company is also a 50% joint venture owner of the German brand TUI Cruises and a 49% shareholder of the Spanish brand Pullmantur. Together these brands operate a combined total of 62 ships with an additional 16 on order as of March 31, 2020. They operate diverse itineraries around the world that call on all seven continents. Additional information can be found on http://www.royalcaribbean.com, http://www.celebritycruises.com, http://www.azamara.com, http://www.silversea.com, http://www.tuicruises.com, http://www.pullmantur.es, http://www.rclcorporate or http://www.rclinvestor.com.

About Norwegian Cruise Line Holdings Ltd.Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) is a leading global cruise company which operates the Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises brands. With a combined fleet of 28 ships with approximately 59,150 berths, these brands offer itineraries to more than 490 destinations worldwide. The Company will introduce nine additional ships through 2027.

Cautionary Statement Concerning Forward-Looking StatementsSome of the statements contained in this release are "forward-looking statements" within the meaning of the U.S. federal securities laws intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this release, including, without limitation, those regarding business strategies, plans, and objectives for future operations (including those regarding efforts made by the panel and future health and safety protocols) are forward-looking statements. Many, but not all, of these statements can be found by looking for words like "expect," "plan," "will," "may," and similar words. Forward-looking statements do not guarantee future performance and may involve risks, uncertainties and other factors which could cause actual results, performance or achievements to differ materially from the future results, performance or achievements expressed or implied in those forward-looking statements. Examples of these risks, uncertainties and other factors include, but are not limited to the impact of: the spread of epidemics, pandemics and viral outbreaks and specifically, the COVID-19 outbreak, including its effect on the ability or desire of people to travel (including on cruises); the ability to develop strategies to enhance health and safety protocols to adapt to the current pandemic environment's unique challenges once operations resume and to otherwise safely resume operations when conditions allow; coordination and cooperation with the CDC, the federal government and global public health authorities to take precautions to protect the health, safety and security of guests, crew and the communities visited and the implementation of any such precautions; and other factors set forth under "Risk Factors" in each respective company's most recently filed Annual Report on Form 10-K, Quarterly Report on Form 10-Q and subsequent filings with the Securities and Exchange Commission. It is not possible to predict or identify all such risks. There may be additional risks that are considered immaterial or which are unknown. The above examples are not exhaustive and new risks emerge from time to time. Such forward-looking statements are based on current beliefs, assumptions, expectations, estimates and projections regarding present and future business strategies and the environment in which we expect to operate in the future. These forward-looking statements speak only as of the date made. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement to reflect any change in our expectations with regard thereto or any change of events, conditions or circumstances on which any such statement was based.

Photo - https://mma.prnewswire.com/media/1200307/1Governor_Mike_Leavitt.jpg Photo - https://mma.prnewswire.com/media/1200308/2Scott_Gottlieb.jpg Photo - https://mma.prnewswire.com/media/1200309/3Helene_Gayle.jpg Photo - https://mma.prnewswire.com/media/1200310/4Julie_Gerberding.jpg Photo - https://mma.prnewswire.com/media/1200311/5Steven_Hinirichs.jpg Photo - https://mma.prnewswire.com/media/1200312/6Micheal_Osterholm.jpg Photo - https://mma.prnewswire.com/media/1200313/7Stephan_Ostroff.jpg Photo - https://mma.prnewswire.com/media/1200314/8William_Rutala.jpg Photo - https://mma.prnewswire.com/media/1200315/9Kate_Walsh.jpg Photo - https://mma.prnewswire.com/media/1200316/10Patrick_Dahlgren.jpg Photo - https://mma.prnewswire.com/media/1200317/11Robin_Lindsay.jpg Logo - https://mma.prnewswire.com/media/1200435/Royal_and_Norwegian_Logo.jpg

https://www.nclhltdinvestor.com/

SOURCE Royal Caribbean Group & Norwegian Cruise Line Holdings Ltd.

See the article here:

Leading Public Health Experts to Oversee Development of Enhanced Cruise Line Health and Safety Standards - PR Newswire UK

Read the Rest...

OPINION | 100 days of lockdown: Success stories need to bring some balance to Covid-19 narrative – News24

§ July 6th, 2020 § Filed under Quantum Medicine Comments Off on OPINION | 100 days of lockdown: Success stories need to bring some balance to Covid-19 narrative – News24

Health workers may be experiencing challenges as they fight Covid-19, but there are also positive developments happening in the field that need to be celebrated, writesMarc Mendelson.

The pandemic of novel coronavirus, SARS-CoV-2, which causes Covid-19, has now claimed over half a million lives and close to 11 million confirmed infections worldwide.1 At home, the seriousness of the situation has required a state of national disaster to be declared, with all the health, social, and economic consequences that it brings.

Lifting of the lockdown brings with it its own challenges for how we, as a society, embrace the new norm of how we live our daily lives and prevent the transmission of the virus to our family, friends and within our communities and at work. There is no getting away from the seriousness of the situation, nor can any broadening of the narrative belittle its gravity.

However, it is time that a modicum of balance is brought to the sense of helplessness and nihilism that is becoming entrenched in society. There are success stories out there, that need to be heard.

Scientific tools

We have remarkable scientific tools at our disposal, that have allowed us to isolate, diagnose, monitor and treat the virus, at a pace not seen with even modern epidemics of Ebola, HIV or previous coronaviruses.

From the start of this epidemic, we were faced with a rapidly evolving field. The last decade has seen quantum leaps in scientific advances that we are now benefitting from, especially in the field of emerging and re-emerging infectious diseases; the identification of SARS-CoV-2 only days after the announcement of atypical pneumonia cases in Wuhan occurred at unprecedented speed, closely followed by a diagnostic test for the virus that allowed outbreak investigations and accelerated understanding of the rapidly expanding global pandemic.

South African expertise in outbreak control, including listeria and drug resistant TB, along with public health expertise in HIV, have allowed for rapid in-depth analysis in a way that rivals many European countries and certainly the US.

In addition, new ways in which we perform clinical trials with "adaptive" designs means that medicines that may be of benefit in treating an emerging infection can be studied rapidly, and a "go-no go" given much earlier than previously possible.

Again, South Africa's rich research community, largely having cut its teeth on infectious diseases and vaccine research during the last 20 years, has swiftly pivoted and begun evaluating a large number of prevention and treatment options. In South Africa, and across the globe, our management of this pandemic has been greatly improved by these advances.

In just a few months, we have acquired enough knowledge to return most people to health, with increasing success in people with severe disease. The pandemic has transfixed society on macro-level numbers, chief among which are the number of cases and the number of deaths. Little attention is given to the number of persons who have recovered.

While about half of the people infected by SARS-CoV-2 will have no symptoms at all (asymptomatic), most of those that do develop symptoms (~80%) will have mild disease, which can be managed at home.

What about outcomes of those that have the most severe disease and require admission to hospital? The most recent DATCOV report from the National Institute for Communicable Diseases (NICD 28th June 2020) tells of 14 555 people admitted to 278 public and private hospitals, countrywide.2

Advances

Although 2 115 (15%) persons had died, 8 189 (56%) had been discharged alive or transferred out, and 4 250 (29%) were still in hospital. Every death is a tragedy, but every person who survives is equally a triumph.

Those successes have been aided by advances in our knowledge of how we treat the sickest patients who are admitted to hospital. Two main advances are the use of the steroid dexamethasone, and alternative ways of delivering more oxygen to patients, short of intubation and mechanically aiding their breathing in the intensive care unit.

Dexamethasone is a commonly used corticosteroid (steroid) available in South Africa and across the world. Recently, results of its use in hospitalised patients with severe Covid-19 were announced by investigators of the UK RECOVERY trial, that set out to study six different possible treatments for Covid-19 at the same time, an example of an adaptive clinical trial alluded to above3.

They found that people admitted to hospital, who needed oxygen support, had a reduction in death of one fifth, and for those on a ventilator in ICU, the reduction in death was one third if they took dexamethasone daily for 10 days. There was no effect for patients who did not require oxygen. This is a major advance as it is the first medicine to show an effect on death rate in severely ill patients with Covid-19.

Another medicine, remdesivir, has been shown in a trial in the US to reduce the duration of symptoms, but did not affect the mortality. Since the publication of these results, doctors in South African hospitals have rapidly started to use these approaches, treating patients with Covid-19 who require oxygen by giving dexamethasone or an equivalent steroid to benefit the patient.

Covid-19 is first and foremost an infection of the lungs, and we are also advancing the way in which we support the sickest patients by giving greater amounts of oxygen in an attempt to reduce the need for people to be ventilated on the ICU.

Like dexamethasone, treating critically ill patients with humidified high flow nasal oxygen (HFNO) is not new, but the global experience, and now ours in South Africa, has taught us that using HFNO in the general wards as well as in the ICU, can improve survival of some patients.

Added to this, the incredibly simple understanding that nursing patients with them lying on their front (proning) also improves oxygen supply to the body. This, too, has been previously used in ICUs, but is now being employed in the wards. Some patients will still need to be ventilated on the ICU.

Despite these sickest patients having the highest risk of dying, we are seeing some patients survive and come off the ventilators to be discharged. The public perception that going into hospital invariably results in death is not the case, despite the very high numbers that do sadly succumb.

This balance in narrative that healthcare workers can provide needs to be matched with the stories of survivors of Covid-19 in South Africa. We need to hear and learn from the experiences of patients, relatives, and staff in our health services, if we are to make further improvements and gain greater insight into how best to manage Covid-19, and its place in society.

Equally, it is absolutely critical that clinical trials of new medicines and vaccines can take place in our country, so that we can ensure that they work in our setting, which is unique in so many ways.

Physical distancing and masks

We welcome the vaccine trials that are under way4, and clinical trials, such as the international World Health Organisation SOLIDARITY trial5among others, that will start shortly in South Africa, looking at new treatment options for Covid-19.

Lastly, the positive benefits of reducing coronavirus transmission by following the simple public health measures of social distancing, universal masking, hand hygiene, regular decontaminating of often-used surfaces, and isolating if symptoms develop, cannot be stressed enough.

These are truly positive rather than negative narratives, in so much as they protect our most vulnerable older populations and those with comorbid medical conditions.

An understandably nihilistic viewpoint of Covid-19, especially for the sickest of our population, needs to be balanced with the positive developments that are happening in the field.

This, coupled with the outstanding ability and dedication of the South African health workforce, gives hope for the coming months, despite the incredible challenges that we face from Covid-19.

-Marc Mendelson isProfessor of Infectious Diseases, Head of Division of Infectious Diseases & HIV Medicine atGroote Schuur Hospital,University of Cape Town and a member of the Ministerial Advisory Committee on Covid-19.

References

1. Johns Hopkins University. Covid-19 Dashboard by the Centre for Systems Science and Engineering (CSSE). Available at https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6 (Accessed on 3rd July 2020)

2. National Institute for Communicable Diseases. Covid-19 Surveillance Reports. Available at https://www.nicd.ac.za/diseases-a-z-index/covid-19/surveillance-reports/ (Accessed on 3rd July 2020)

Randomised Evaluation of Covid-19 Therapy (RECOVERY): Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of Covid-19. Availablehttps://www.recoverytrial.net/files/recovery_dexamethasone_statement_160620_v2final.pdf (Accessed on 3rd July 2020)

3. University of Witwatersrand. The first Covid-19 vaccine trial is South Africa begins. Available at http://www.wits.ac.za/covid19vaccine/ (Accessed on 3rd July 2020)

4. World Health Organisation. "Solidarity" clinical trial for Covid-19 treatments. Available at https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments (Accessed on 3rd July 2020)

See the article here:

OPINION | 100 days of lockdown: Success stories need to bring some balance to Covid-19 narrative - News24

Read the Rest...

Global Medical Imaging Reagents Market to Witness Heightened Growth During the Period 2017 2025 – Jewish Life News

§ July 6th, 2020 § Filed under Quantum Medicine Comments Off on Global Medical Imaging Reagents Market to Witness Heightened Growth During the Period 2017 2025 – Jewish Life News

Medical imaging is used to define the use of conventional and sophisticated diagnostic practices. Traditional imaging techniques like computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, X-ray, and nuclear medicine (NM) usually analyze morphology and anatomy but are unable to detect changes at the molecular level. However, new developments in biotechnology allow imaging at the molecular and cellular level, making way for early diagnosis and treatment of disease. Medical imaging reagents play a very crucial role in this medical revolution.

Medical Imaging Reagents Market: Drivers and Restraints

Technological advances used in medical imaging reagents is moving forward at a rapid pace. These technologies include biologic targeting, microfluidics, nanotechnology, protein engineering and supramolecular chemistry. Rapid development across a number of technology fields promise to change the medical imaging industry by enabling novel imaging reagents and unique market opportunities. The high market growth rate for medical imaging reagents results in the adoption of personalized medicine, which demands a molecular approach toward the early diagnosis and monitoring of drugs. At the same time, the impact of enormous advances in proteomics and genomics are generating biomarkers of diseases. This rich source of biologic targets can be exploited by medical imaging reagents for detection of early plaques formed in Alzheimers disease or early detection of cancer cells.

To remain ahead of your competitors, request for a sample [emailprotected]

https://www.persistencemarketresearch.com/samples/14242

Medical Imaging Reagents Market: Segmentation

On the basis of technology, the medical imaging reagents market can be segmented into:

On the basis of application, the medical imaging reagents market can be segmented into:

On the basis of product type, the medical imaging reagents market can be segmented into:

On the basis of end user, the medical imaging reagents market can be segmented into:

In-vivo optical imaging reagents are key technologies for the drug development industry, as they allow for imaging of drug distribution and pharmacokinetics in mammalian animals. Such studies are critical in assisting pharmaceutical companies to eliminate poor drug candidates prior to expensive clinical trials.

To receive extensive list of important regions, Request Methodology here @

https://www.persistencemarketresearch.com/methodology/14242

Medical Imaging Reagents Market: Overview

Optical imaging reagents are an enabling technology in proteomics, genomics, in-vitro diagnostics industries and cellular analysis. Fluorescent dyes, probes, and proteins are essential components of the assays and techniques that are the basis for these fields of research, including DNA sequencing, polymerase chain reaction (PCR), immunoassays and cell-based fluorescence analysis. Growth in these markets will continue to drive demand for in-vitro imaging reagents. The medical imaging reagents industry is composed of a core group of companies that are leaders in life sciences R&D tools and medical imaging instrumentation. A major competitive strategy for achieving success in medical imaging reagents businesses has been acquiring unique technology in fluorescent proteins, fluorescence dyes, and probes, quantum dots, or nanotechnology. Biotechnology or nanotechnology companies are central to the development of these technologies and, thus, serve as innovative forces.

Medical Imaging Reagents Market: Region-wise Outlook

Geographically, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America dominates the medical imaging reagents market due to a rapid adoption of several types of modalities by end users, technological advancements, the prevalence of chronic diseases such as cancer, cardiovascular disease, and others. The North America market is followed by Europe and Asia-Pacific. Europe is the second largest market for medical imaging reagents due to growing health awareness among people and increasing number of research and development activities. Asia-Pacific is expected to grow at a faster pace due to rise in population, an increase in opportunity for clinical and preclinical studies at low costs, and government support for research and development activities in the medical imaging reagents market.

You Can Request for TOC Here @ https://www.persistencemarketresearch.com/toc/14242

Medical Imaging Reagents Market: Key Players

Some of the major market players include Bayer Healthcare AG, Lantheus Medical Imaging, Inc., GE Healthcare, Bracco Imaging SpA, Thermo Fisher Scientific, Inc. Mallinckrodt Pharmaceuticals, and Siemens Healthcare. A key to maintaining a competitive advantage in the future medical imaging reagents market will be to continue an aggressive strategy of acquiring novel technologies that enhance the functionality and biocompatibility of present imaging reagents.

See original here:

Global Medical Imaging Reagents Market to Witness Heightened Growth During the Period 2017 2025 - Jewish Life News

Read the Rest...

Addressing the potential impact of coronavirus disease (COVID-19) on Big Data in the Healthcare & Pharmaceutical Market Top Big Data in the…

§ July 6th, 2020 § Filed under Quantum Medicine Comments Off on Addressing the potential impact of coronavirus disease (COVID-19) on Big Data in the Healthcare & Pharmaceutical Market Top Big Data in the…

Big Data originally emerged as a term to describe datasets whose size is beyond the ability of traditional databases to capture, store, manage and analyze. However, the scope of the term has significantly expanded over the years. Big Data not only refers to the data itself but also a set of technologies that capture, store, manage and analyze large and variable collections of data, to solve complex problems.

Amid the proliferation of real-time and historical data from sources such as connected devices, web, social media, sensors, log files and transactional applications, Big Data is rapidly gaining traction from a diverse range of vertical sectors. The healthcare and pharmaceutical industry is no exception to this trend, where Big Data has found a host of applications ranging from drug discovery and precision medicine to clinical decision support and population health management.

Get Free Sample PDF Copy of Report @https://www.researchmoz.us/enquiry.php?type=S&repid=1863306

SNS Telecom & IT estimates that Big Data investments in the healthcare and pharmaceutical industry will account for nearly $4.7 Billion in 2018 alone. Led by a plethora of business opportunities for healthcare providers, insurers, payers, government agencies, pharmaceutical companies and other stakeholders, these investments are further expected to grow at a CAGR of approximately 12% over the next three years.

The Big Data in the Healthcare & Pharmaceutical Industry: 2018 2030 Opportunities, Challenges, Strategies & Forecasts report presents an in-depth assessment of Big Data in the healthcare and pharmaceutical industry including key market drivers, challenges, investment potential, application areas, use cases, future roadmap, value chain, case studies, vendor profiles and strategies. The report also presents market size forecasts for Big Data hardware, software and professional services investments from 2018 through to 2030. The forecasts are segmented for 8 horizontal submarkets, 5 application areas, 37 use cases, 6 regions and 35 countries.

The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.

Topics Covered

The report covers the following topics:

Forecast Segmentation

Market forecasts are provided for each of the following submarkets and their subcategories:

Hardware, Software & Professional Services

Horizontal Submarkets

Application Areas

Use Cases

Regional Markets

Country Markets

Argentina, Australia, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany, India, Indonesia, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Norway, Pakistan, Philippines, Poland, Qatar, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Taiwan, Thailand, UAE, UK, USA

Key Questions Answered

The report provides answers to the following key questions:

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid=1863306

Key Findings

The report has the following key findings:

List of Companies Mentioned

For More Information Kindly Contact: ResearchMoz Mr. Rohit Bhisey, 90 State Street, Albany NY, United States 12207 Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email: [emailprotected] Media Release @ https://www.researchmoz.us/pressrelease Follow me on Blogger: https://trendingrelease.blogspot.com/

Continue reading here:

Addressing the potential impact of coronavirus disease (COVID-19) on Big Data in the Healthcare & Pharmaceutical Market Top Big Data in the...

Read the Rest...

Dhaka University is in need of reinvention – The Financial Express

§ July 6th, 2020 § Filed under Quantum Medicine Comments Off on Dhaka University is in need of reinvention – The Financial Express

Syed Badrul Ahsan | Published: July 05, 2020 21:50:03

Dhaka University will be a hundred years old next year. The enthusiasm that will go into the celebrations of its centenary are already being felt, a broad hint of it being the manner in which current and former alumni cheerfully observed its 99th founding anniversary on the first day of July.

The university, for all the impediments which have come its way in recent times, remains the nation's premier institution of higher learning. Indeed, there are people who fondly refer to it as the Oxford of the East, even if that reputation has taken a good deal of battering over the years for reasons that ought to be obvious.

Certainly the greatest tribute which can be paid to Dhaka University comes associated with its past. And one of course must begin through recalling the endeavours of men like Nawab Salimullah, who remains a point of reference in any discussion of the university. Mention needs to be made too of the British colonial power, for in its annulment of the partition of Bengal in 1911, it offered the consolation of a promise of a university for eastern Bengal.

Since 1921, therefore, Dhaka University has come a long way. It has weathered many a storm, has created history at nearly every turn and has produced scholars who have gone out into the wider world seeking to disseminate the Bengali scholarly and cultural ethos across the globe.

And yet the reputation of a university rests not merely on past laurels but on present achievements. In these past many years, the placement of Bangladesh's universities among the notable institutions of higher learning on the global scale has been frustrating, for that placement has not been there at all.

It has been particularly galling for Dhaka University, indeed for those who have taken pride in its past, to be informed that it has no place in the world's intellectual spaces. Lack of research, absence of world class education, a preponderance of politics and a general sense of lethargy has appeared to undermine the university.

That leads one to a crucial point, which is that Dhaka University needs to reinvent itself. But reinvention is not a proposition that can be put into implementation mode as soon as it is mouthed. There are the difficulties along the way, if one has cared to observe the recent budget for public universities announced by the University Grants Commission. The Tk 84.85 billion e budget for 2020-21 covers 46 public universities. Of the amount, Dhaka University is the recipient of slightly over Tk 8.30 billion, which is the biggest chunk when compared to the amount handed out to the remaining 45 universities. The problem comes in with the allocation for research, in all these public universities. A mere Tk 660 million has been doled out for research in higher education.

And that indeed is where the public universities are stymied. For years academics and education experts have argued for a decent quantum of money to be thrown into research.

In fact, in an era where education should be among the topmost priorities in public planning, our schools, colleges and universities have remained on the fringes of policy considerations. Now take this Tk 660 million and try working out a scheme for research. And remember this amount is for all 46 public universities. How much of it, then, can Dhaka University expect to get for itself? And to what degree will that suffice for meaningful research for the university?

A general complaint about Dhaka University insofar as its absence on the scale of global rankings is concerned has been its sheer poverty in terms of research. The new allocation only maintains the disturbing status quo.

Yet Dhaka University needs to link its present with its past. The past, unquestionably political in nature and therefore contributory to the making of national history, was also defined by scholarly pursuits on the watch of a large number of its vice chancellors. It is on the basis of that past that the present ought to be shaped, at both the individual levels of the various departments of the university and the collective endeavours of the university as a whole.

Obviously encouraging is the presence of a vibrant presence of students, a heritage that surely must not wither way. Equally remarkable has been the crop of teachers generationally coming forth with ideas commensurate with the times. It is such energy which needs harnessing, through opening up the departments --- in the humanities, sciences, et cetera --- to explorations of newer concepts. Dhaka University is today in need of an explosion of energy that can truly restore its erstwhile reputation as the Oxford of the East.

As it enters its hundredth year, Dhaka University must catch up with the times. Good, purposeful libraries in the departments, apart from the central library of the university, equipped with the most modern works and treatises on the subjects covered by the institution are an imperative. Perhaps the time is here for the university to explore the possibilities of purposeful schools -- and here the role of the government as also of public intellectuals will be important --- in the humanities, sciences and social sciences --- being set up.

Universities are places for the pursuit of merit. Journals rich in content ---in medicine, physics, engineering, literature, politics, history, philosophy, law, international relations, et cetera --- and published periodically and regularly can only heighten the appeal of Dhaka University on a global scale. Additionally, teachers' unions and students' unions should reconfigure themselves in the larger interest of both the university administration and general students' welfare.

Dhaka University is part of history. Its glory days have covered the period from 1948 through 1952 through 1962 through 1969 and all the way to 1971. Post-liberation, it has been a powerful symbol of resistance to all manner of authoritarian politics. Its students and teachers have suffered and died in some of the darkest moments of the nation's history.

Dhaka University goes on embodying the aspirations of the nation as it lights the spark of intellectual inquiry in the young men and women who today occupy its classrooms, looking beyond the present and peering into the future.

Syed Badrul Ahsan is writer and senior journalist.

ahsan.syedbadrul@gmail.com

See the original post here:

Dhaka University is in need of reinvention - The Financial Express

Read the Rest...

Nanomaterials in Theranostics Market Growth By Manufacturers, Type And Application, Forecast To 2026 – 3rd Watch News

§ July 6th, 2020 § Filed under Nanomaterials Comments Off on Nanomaterials in Theranostics Market Growth By Manufacturers, Type And Application, Forecast To 2026 – 3rd Watch News

Therapeutic Applications

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=306415&utm_source=3WN&utm_medium=888

The Nanomaterials in Theranostics market report provides successfully marked contemplated policy changes, favorable circumstances, industry news, developments, and trends. This information can help readers fortify their market position. It packs various parts of information gathered from secondary sources, including press releases, web, magazines, and journals as numbers, tables, pie-charts, and graphs. The information is verified and validated through primary interviews and questionnaires. The data on growth and trends focuses on new technologies, market capacities, raw materials, CAPEX cycle, and the dynamic structure of the Nanomaterials in Theranostics market.

This study analyzes the growth of Nanomaterials in Theranostics based on the present, past and futuristic data and will render complete information about the Nanomaterials in Theranostics industry to the market-leading industry players that will guide the direction of the Nanomaterials in Theranostics market through the forecast period. All of these players are analyzed in detail so as to get details concerning their recent announcements and partnerships, product/services, and investment strategies, among others.

Sales Forecast:

The report contains historical revenue and volume that backing information about the market capacity, and it helps to evaluate conjecture numbers for key areas in the Nanomaterials in Theranostics market. Additionally, it includes a share of each segment of the Nanomaterials in Theranostics market, giving methodical information about types and applications of the market.

Reasons for Buying Nanomaterials in Theranostics Market Report

This report gives a forward-looking prospect of various factors driving or restraining market growth.

It renders an in-depth analysis for changing competitive dynamics.

It presents a detailed analysis of changing competition dynamics and puts you ahead of competitors.

It gives a six-year forecast evaluated on the basis of how the market is predicted to grow.

It assists in making informed business decisions by performing a pin-point analysis of market segments and by having complete insights of the Nanomaterials in Theranostics market.

This report helps the readers understand key product segments and their future.

Have Any Query? Ask Our Expert @ https://www.marketresearchintellect.com/need-customization/?rid=306415&utm_source=3WN&utm_medium=888

In the end, the Nanomaterials in Theranostics market is analyzed for revenue, sales, price, and gross margin. These points are examined for companies, types, applications, and regions.

To summarize, the global Nanomaterials in Theranostics market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Biopsy Punch Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Laparoscopic and Open Hernia Mesh Repair Surgery Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Gene Panel Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Body Wash and Shower Gel Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Blood Glucose Monitoring Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Original post:

Nanomaterials in Theranostics Market Growth By Manufacturers, Type And Application, Forecast To 2026 - 3rd Watch News

Read the Rest...

Carbon Nanotubes and Nanomaterials Market Growth By Manufacturers, Type And Application, Forecast To 2026 – 3rd Watch News

§ July 6th, 2020 § Filed under Nanomaterials Comments Off on Carbon Nanotubes and Nanomaterials Market Growth By Manufacturers, Type And Application, Forecast To 2026 – 3rd Watch News

Other

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=286818&utm_source=3WN&utm_medium=888

The Carbon Nanotubes and Nanomaterials market report provides successfully marked contemplated policy changes, favorable circumstances, industry news, developments, and trends. This information can help readers fortify their market position. It packs various parts of information gathered from secondary sources, including press releases, web, magazines, and journals as numbers, tables, pie-charts, and graphs. The information is verified and validated through primary interviews and questionnaires. The data on growth and trends focuses on new technologies, market capacities, raw materials, CAPEX cycle, and the dynamic structure of the Carbon Nanotubes and Nanomaterials market.

This study analyzes the growth of Carbon Nanotubes and Nanomaterials based on the present, past and futuristic data and will render complete information about the Carbon Nanotubes and Nanomaterials industry to the market-leading industry players that will guide the direction of the Carbon Nanotubes and Nanomaterials market through the forecast period. All of these players are analyzed in detail so as to get details concerning their recent announcements and partnerships, product/services, and investment strategies, among others.

Sales Forecast:

The report contains historical revenue and volume that backing information about the market capacity, and it helps to evaluate conjecture numbers for key areas in the Carbon Nanotubes and Nanomaterials market. Additionally, it includes a share of each segment of the Carbon Nanotubes and Nanomaterials market, giving methodical information about types and applications of the market.

Reasons for Buying Carbon Nanotubes and Nanomaterials Market Report

This report gives a forward-looking prospect of various factors driving or restraining market growth.

It renders an in-depth analysis for changing competitive dynamics.

It presents a detailed analysis of changing competition dynamics and puts you ahead of competitors.

It gives a six-year forecast evaluated on the basis of how the market is predicted to grow.

It assists in making informed business decisions by performing a pin-point analysis of market segments and by having complete insights of the Carbon Nanotubes and Nanomaterials market.

This report helps the readers understand key product segments and their future.

Have Any Query? Ask Our Expert @ https://www.marketresearchintellect.com/need-customization/?rid=286818&utm_source=3WN&utm_medium=888

In the end, the Carbon Nanotubes and Nanomaterials market is analyzed for revenue, sales, price, and gross margin. These points are examined for companies, types, applications, and regions.

To summarize, the global Carbon Nanotubes and Nanomaterials market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Smart Healthcare Products Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Wound Care And Medical Device Coatings Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Textile Films Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Antimicrobial Plastics Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Non-Woven Adhesives Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

View original post here:

Carbon Nanotubes and Nanomaterials Market Growth By Manufacturers, Type And Application, Forecast To 2026 - 3rd Watch News

Read the Rest...

3D Printed Nanomaterials Market Growth By Manufacturers, Type And Application, Forecast To 2026 – 3rd Watch News

§ July 6th, 2020 § Filed under Nanomaterials Comments Off on 3D Printed Nanomaterials Market Growth By Manufacturers, Type And Application, Forecast To 2026 – 3rd Watch News

Other

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=355157&utm_source=3WN&utm_medium=888

The 3D Printed Nanomaterials market report provides successfully marked contemplated policy changes, favorable circumstances, industry news, developments, and trends. This information can help readers fortify their market position. It packs various parts of information gathered from secondary sources, including press releases, web, magazines, and journals as numbers, tables, pie-charts, and graphs. The information is verified and validated through primary interviews and questionnaires. The data on growth and trends focuses on new technologies, market capacities, raw materials, CAPEX cycle, and the dynamic structure of the 3D Printed Nanomaterials market.

This study analyzes the growth of 3D Printed Nanomaterials based on the present, past and futuristic data and will render complete information about the 3D Printed Nanomaterials industry to the market-leading industry players that will guide the direction of the 3D Printed Nanomaterials market through the forecast period. All of these players are analyzed in detail so as to get details concerning their recent announcements and partnerships, product/services, and investment strategies, among others.

Sales Forecast:

The report contains historical revenue and volume that backing information about the market capacity, and it helps to evaluate conjecture numbers for key areas in the 3D Printed Nanomaterials market. Additionally, it includes a share of each segment of the 3D Printed Nanomaterials market, giving methodical information about types and applications of the market.

Reasons for Buying 3D Printed Nanomaterials Market Report

This report gives a forward-looking prospect of various factors driving or restraining market growth.

It renders an in-depth analysis for changing competitive dynamics.

It presents a detailed analysis of changing competition dynamics and puts you ahead of competitors.

It gives a six-year forecast evaluated on the basis of how the market is predicted to grow.

It assists in making informed business decisions by performing a pin-point analysis of market segments and by having complete insights of the 3D Printed Nanomaterials market.

This report helps the readers understand key product segments and their future.

Have Any Query? Ask Our Expert @ https://www.marketresearchintellect.com/need-customization/?rid=355157&utm_source=3WN&utm_medium=888

In the end, the 3D Printed Nanomaterials market is analyzed for revenue, sales, price, and gross margin. These points are examined for companies, types, applications, and regions.

To summarize, the global 3D Printed Nanomaterials market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Telecom Towers Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Train Communication Gateways Systems Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Telecom Outsourcing Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Cyber Security Software Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Application Development Software Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

See the original post:

3D Printed Nanomaterials Market Growth By Manufacturers, Type And Application, Forecast To 2026 - 3rd Watch News

Read the Rest...

Thirteen UChicago faculty receive named, distinguished service professorships – UChicago News

§ July 6th, 2020 § Filed under Nanomaterials Comments Off on Thirteen UChicago faculty receive named, distinguished service professorships – UChicago News

Thirteen University of Chicago faculty members have received named professorships or have been appointed distinguished service professors.

Profs. Clifford Ando, John Birge, Frances Ferguson, Vinay Kumar, Ka Yee C. Lee and Linda Waite received distinguished service professorships, while Profs. Neil Brenner, Junhong Chen, Scott Eggener, Timothy Harrison, Eric Pamer, Mercedes Pascual and Brook Ziporyn received named professorships.

Scott Eggener has been named the Bruce and Beth White Family Professor in the Departments of Surgery and Radiology.

Eggener is a urologic oncologist and surgeon who specializes inprostate,kidneyand testicular cancer.He is Vice Chair of Urology, senior scholar at the Bucksbaum Institute for Clinical Excellenceand co-director of UChicago MedicineHigh-Risk and Advanced Prostate Cancer Clinic (UCHAP).

He has published more than 250 research papers, chaired or participated in multiple national cancer guideline panels, had editorial roles at multiple journalsand is on the executive board of International Volunteers in Urology.

Vinay Kumar has been named the Lowell T. Coggeshall Distinguished Service Professor in the Department of Pathology.

Kumar is a pioneer in the field of the cellular and molecular biology of natural killer cells and a global leader in medical education. He was one of the first to propose the existence of a novel subset of lymphoid cells with antileukemic activity, subsequently identified as natural killer cells. His research has focused on understanding the origin and differentiation of these cells and their role in the rejection of transplanted bone marrow. His group also discovered that mutations in the human perforin gene give rise to severe and fatal disorders of immune dysregulation. This paradigm-shifting work has been recognized as a pillar of immunology by the Journal of Immunology.

He is the senior editor and co-author of five pathology textbooks, including Robbins and Cotran Pathologic Basis of Disease, which has been translated into more than 13 languages and is the most widely used pathology text in the world. He has received many honors for his research, including election as a fellow of the American Association for Advancement of Sciences in 2004, and the 2019 Gold Headed Cane Award, which is the highest honor granted by the American Society for Investigative Pathology.

Eric Pamer has been named the first Donald F. Steiner Professor in the Departments of Medicine and Pathology and the College.

Pamer,a physician who specializes in infectious diseases,investigates host defense against infections and the role of commensal bacteria in disease resistance. His research focuses on mechanisms by which the microbiome confers resistance to a wide range of microbial pathogens. His lab has discovered and characterized interactions between pathogenic and beneficial bacteria and their mammalian hosts, and has identified multiple novel mechanisms of antimicrobial resistance that can be exploited to fight highly antibiotic-resistant pathogens.

He joined the university last year as inaugural director of the Duchossois Family Institute at the University of Chicago Medicine, which seeks to carry out groundbreaking research on how the human immune system, microbiome and genetics interact to maintain health.

Pamer is a member of the American Association of Physicians and of the Bill and Melinda Gates Foundations Global Health Scientific Advisory Committee. He has published over 200 articles and book chapters.

Mercedes Pascual has been named the Louis Block Professor in the Department of Ecology and Evolution and the College.

Pascual studies the ecology and evolution of infectious diseases. She is a leader in the field of how disease spreads through populations based on changes to the environment, in particular how climate variability and climate change affect vector-borne and water-borne diseases like malaria and cholera.

Her work spans multiple temporal, spatial and organizational scales, from decades-long patterns in disease incidence to within megacity maps of infection risk, to the molecular changes in pathogens as they evolve to escape the immune system. She is addressing how transmission dynamics and evolution interact to generate strain structure in local populations of the malaria parasite, and how this diversity affects responses to intervention measures. She combines mathematical, statistical and computational approaches with collaboration with public health and research partners around the world.

Pascual is a fellow of the American Association for the Advancement of Science, a member of the American Academy of Arts and Sciencesand a recipient of the 2014 R. MacArthur Award of the Ecological Society of America.

Clifford Andohas been named the David B. and Clara E. Stern Distinguished Service Professor in the Departments of Classics and History and the College.

A prolific author, Ando writes on a wide range of topics within the histories of religion, law and government in the ancient world. Recently he has turned his attention to issues in legal history, the nature of domination in republican empiresand the conduct of legal and political theory in contexts of weak state power.

He is currently working on a collaborative project to produce a new edition of the surviving texts of Roman statutes, and a rhetorical and sociolinguistic study of legal Latin from archaic Rome to the medieval period.

Ando served as the Lucy Shoe Merritt Scholar in Residence from 2014 to 2015 at the American Academy in Rome, and received the 2012 Frederich Wilhelm Bessel Research Prize from the Alexander von Humboldt Foundation. He has been a visiting scholar or research fellow at 12 other institutions outside the United States, including in France, Germany, England, New Zealandand South Africa.

FrancesFergusonhas been named the Mabel Greene Myers Distinguished Service Professor in the Department of English Language and Literature and the College.

While she focuses her scholarship on writing from the 18th century and the Romantic period, Ferguson has wide-ranging scholarly interests, including such topics as pornography, Edmund Burkes and Immanuel Kants accounts of aesthetics and philosopher Jeremy Benthams thinking on law and constitutions. She has held several visiting professorships, most recently at the University of Cambridge. There, Ferguson gave a public lecture about the relationship between Bitcoin and Blockchain, the place of whales in the Bitcoin community, and the tension between using Bitcoin for currency and using it for investment.

Her forthcoming book aims to describe 18th- and early 19th-century efforts to democratize education. Ferguson is a Fellow of the American Academy of Arts and Sciences, and in 2011, she received the Distinguished Scholar Award for lifetime achievement from the Keats-Shelley Association of America.

Timothy Harrisonhas been named the Randy L. and Melvin R. Berlin Assistant Professor of Renaissance and Early Modern English Literature in the Department of English Language and Literature and the College.

He focuses his scholarship on how early modern literature intersects with multidisciplinary fields of study, including philosophy, theology and the sciences. Currently, Harrison is the director of the undergraduate program in Renaissance Studies, a program he developed with UChicago historian Ada Palmer.

His first book,Coming To: Consciousness and Natality in Early Modern England, will be published by the University of Chicago Press in fall 2020. This book examines the role played by poetry in the emergence of the concept of consciousness through the lens of the poetry and prose of John Milton and Thomas Traherne alongside such philosophers as Ren Descartes and John Locke.

His current work includes researching and writingThe Being of Effort in Early Modernity, which extends his work on consciousness into the realm of biology by exploring how Milton's poetry develops an account of life as it is lived that draws on the resources of both the Reformation theology of the will and the philosophical ideas expressed by such thinkers as Thomas Hobbes, Margaret Cavendishand Anne Conway.

Ka Yee C. Lee has been named theDavid Lee Shillinglaw Distinguished Service Professor of Chemistry and the College.

Lee was appointed Provost of the University of Chicago in February 2020. She previously served as the Vice Provost for Research, working with deans, faculty and researchers across the University to increase access to research funding and resources. She has played a lead role in the Universitys activities and partnerships in Hong Kong over the past six years, including the opening ofThe Hong Kong Jockey Club University of Chicago Academic Complex | The University of Chicago Francis and Rose Yuen Campus in Hong Kong.

Lees research focus lies in the area of membrane biophysics, and she is the author or co-author of more than 125 scholarly publications.Her laboratory carries out fundamental studies on the interactions between lipids and proteins. Her work brings a greater understanding of diseases that are the result of deficient or abnormal protein-lipid interactions, such as respiratory distress syndrome and Parkinsons disease.

Lee is an elected member of the College of Fellows of the American Institute for Medical and Biological Engineering and a fellow of the American Physical Society. Previously, she was a Searle Scholar, a David and Lucile Packard Fellow for Science and Engineeringand a Sloan Research Fellow. She received the Universitys Llewellyn John and Harriet Manchester Quantrell Award for Excellence in Undergraduate Teaching in 2007and was the inaugural recipient of the Arthur L. Kelly Prize for Exceptional Faculty Service in the Physical Sciences Division in 2013.

Neil Brennerhas been named the Lucy Flower Professor of Urban Sociology in the Department of Sociology and the College.

His work, in both teaching and writing, centers onthe theoretical, conceptual and methodological dimensions of urban questions, especially in relation to the remaking of cities and their hinterlands under contemporary supply chain capitalism.Brenner has made influential contributions to scholarly debates on critical urban theory, the critique of capitalist urbanization, urban restructuring, state space, the political economy of rescaling, variegated neoliberalization and planetary urbanization.

Brenners most recent books areNew Urban Spaces: Urban Theory and the Scale QuestionandCritique of Urbanization: Selected Essays.Prior to joining UChicago in July 2020, Brenner was a Professor of Urban Theory at the Harvard Graduate School of Design.

Linda Waitehas been named as the George Herbert Mead Distinguished Service Professor in the Department of Sociology and the College.

Her research interests include social demography, aging, the family, sexuality, and health, as well as the links between biology, psychology, and the social world. Waite is Senior Fellow at NORC at the University of Chicago. Her current research focuses on the National Social Life, Health, and Aging Project (NSHAP), which is yielding groundbreaking knowledge about the links between the social world and physical, cognitive and emotional health among older Americans.

In addition to her position at NORC, she also serves as a co-director of the University of Chicagos MD/PhD Program in Medicine, the Social Sciences, and Aging, and chairs the Committee on Demographic Training at the University of Chicago and NORC.

John R. Birge has been named the Hobart W. Williams Distinguished Service Professor of Operations Management.

Birge studies mathematical modeling of systems under uncertainty, especially for maximizing operational and financial goals, using the methodologies of stochastic programming and large-scale optimization. He is the recipient of the Best Paper Award from the Japan Society for Industrial and Applied Mathematics, the Institute for Operations Research and the Management Sciences Fellows Award,the Institute of Industrial Engineers Medallion Award, and was elected to the National Academy of Engineering.

A former dean of the Robert R. McCormick School of Engineering and Applied Sciences at Northwestern University, he has consulted for a variety of firms including the University of Michigan Hospitals, Deutsche Bank, Allstate Insurance Companyand Morgan Stanley, and uses cases from these experiences in his teaching.

Birge is a member of the Institute for Operations Research and the Management Sciences, theMathematical Optimization Society, the Mathematical Association of Americaand Sigma Xi.

Brook A. Ziporyn has been named the Mircea Eliade Professor in the Divinity School and the College.

A scholar of ancient and medieval Chinese religion and philosophy, Ziporyn is a premier expositor and translator of some of the most complex philosophical texts and concepts in Chinese religious traditions with a particular expertise in the Tiantai school of Buddhist thought. He also teaches comparative philosophy.

The author of seven books on issues in Taoism, Buddhismand Chinese thought, Ziporyn is currently working on two projects: one a cross-cultural inquiry into the themes of death, time and perception, and the otheran exposition of atheism as a form of religious and mystical experience in the intellectual histories of Europe, India and China.

Junhong Chen has been named the Crown Family Professor of Molecular Engineering.

Chen serves as lead water strategist at Argonne National Laboratory. His research interest lies in molecular engineering of nanomaterials and nanodevices, particularly hybrid nanomaterials featuring rich interfaces and nanodevices for sustainable energy and the environment. Chen has made seminal contributions to hybrid nanomaterials and the molecular engineering of various sensors and energy devices.

His research has led to nine issued U.S. patents, five pending patents, and 13 licensing agreements. He is a pioneer in technology translation and commercialization; his start-up company NanoAffix, which he founded to commercialize real-time water sensors based on 2-D nanomaterials, is a recipient of the 2016 Wisconsin Innovation Award.

Chen is an elected fellow of the National Academy of Inventors and the American Society of Mechanical Engineers. He is a recipient of the International Association of Advanced Materials Medal.

Read the rest here:

Thirteen UChicago faculty receive named, distinguished service professorships - UChicago News

Read the Rest...

Cybersecurity in the quantum era – ETCIO.com

§ July 6th, 2020 § Filed under Quantum Computer Comments Off on Cybersecurity in the quantum era – ETCIO.com

By Tirthankar Dutta

On October 23rd, 2019, Google claimed that they had achieved Quantum supremacy by solving a particularly difficult problem in 200 seconds by using their quantum computer, which is also known as "sycamore." This performance was compared with a Supercomputer known as 'Summit" and built by IBM. According to Google, this classical computer would have taken 10,000 years to solve the same problem.

The advancement of large quantum computers, along with the more computational power it will bring, could have dire consequences for cybersecurity. It is well known that important problems such as factoring, whose considered hardness ensures the security of many widely used protocols (RSA, DSA, ECDSA), can be solved efficiently, if a quantum computer that is sufficiently large, "fault-tolerant" and universal, is developed. However, addressing the imminent risk that adversaries equipped with quantum technologies pose is not the only issue in cybersecurity where quantum technologies are bound to play a role.

Because quantum computing speeds up prime number factorization, computers enabled with that technology can easily break cryptographic keys by quickly calculating or exhaustively searching secret keys. A task considered computationally infeasible by a conventional computer becomes painfully easy, compromising existing cryptographic algorithms used across the board. In the future, even robust cryptographic algorithms will be substantially weakened by quantum computing, while others will no longer be secure at all:

There would be many disconnects on the necessity to change the current cryptographic protocols and infrastructure to counter quantum technologies in a negative way, but we can't deny the fact that future adversaries might use this kind of technology to their benefit. As it allows them to work on millions of computations in parallel, exponentially speeding up the time it takes to process a task.

According to the National, Academies Study notes, "the current quantum computers have very little processing power and are too error-prone to crack today's strong codes. The future code-breaking quantum computers would need 100,000 times more processing power and an error rate 100 times better than today's best quantum computers have achieved. The study does not predict how long these advances might takebut it did not expect them to happen within a decade."

But does this mean that we should wait and watch the evolution of quantum computing, or should we go back to our drawing board to create quantum-resistant cryptography? Thankfully, researchers have been working on a public-key cryptography algorithm that can counter code-breaking efforts by quantum computers. US National Institute of Standards and Technology (NIST) evaluating 69 potential new methods for what it calls "post-quantum cryptography." The institution expects to have a draft standard by 2024, which would then be added to web browsers and other internet applications and systems

No matter when dominant quantum computing arrives, it poses a large security threat. Because the process of adopting new standards can take years, it is wise to begin planning for quantum-resistant cryptography now.

The author is SVP and Head of Information Security at Infoedge.

DISCLAIMER: The views expressed are solely of the author and ETCIO.com does not necessarily subscribe to it. ETCIO.com shall not be responsible for any damage caused to any person/organisation directly or indirectly.

Read this article:

Cybersecurity in the quantum era - ETCIO.com

Read the Rest...

Essential Science: Severe warming recorded at the South Pole – Digital Journal

§ July 6th, 2020 § Filed under Quantum Computer Comments Off on Essential Science: Severe warming recorded at the South Pole – Digital Journal

The finding that the South Pole is warming faster than any other place on Earth comes from Ohio University. This is attributed to natural tropical climate variability, which is the product of rises in the level of greenhouse gas. A sign of the extent of warming has been found with studies in the waters. Under glaciers some extremely warm waters have been recorded. In one case the level recorded was more than two degrees above freezing, relating to the water flow beneath the Thwaites Glacier, which is part of the Western Antarctic Ice Sheet.

Lake Pyasino is of glacier origin. It is situated in the southwestern part of the lowlands of the North-Siberian on the territory of Krasnoyarsk territory, approximately 20 kilometers from Norilsk in Russia.

Russian Geography

NASA Earth Observatory map by Lauren Dauphin, using Reference Elevation Model of Antarctica (REMA) data from the Polar Geospatial Center at the University of Minnesota.

NASA

Mountain range in Antarctica

euphro (CC BY-SA 2.0)

The green scum shown in this image is the worst algae bloom Lake Erie has experienced in decades. Vibrant green filaments extend out from the northern shore.

Jesse Allen and Robert Simmon

Robert Swan and his son, Barney will begin an expedition to the South Pole in November, relying only on renewable technologies.

2041 Climate Force

File photo: Donating blood

Continue reading here:

Essential Science: Severe warming recorded at the South Pole - Digital Journal

Read the Rest...

– Making science fiction a reality: Teleportation helps to create live musical performance – Design Products & Applications

§ July 6th, 2020 § Filed under Quantum Computer Comments Off on – Making science fiction a reality: Teleportation helps to create live musical performance – Design Products & Applications

06 July 2020

However, a new study has described how its status in science fact could actually be employed as another, and perhaps unlikely, form of entertainment live music.

Dr Alexis Kirke, Senior Research Fellow in the Interdisciplinary Centre for Computer Music Research at the University of Plymouth (UK), has for the first time shown that a human musician can communicate directly with a quantum computer via teleportation.

The result is a high-tech jamming session, through which a blend of live human and computer-generated sounds come together to create a unique performance piece.

Speaking about the study, Dr Kirke said: "The world is racing to build the first practical and powerful quantum computers, and whoever succeeds first will have a scientific and military advantage because of the extreme computing power of these machines.

This research shows for the first time that this much-vaunted advantage can also be helpful in the world of making and performing music. No other work has shown this previously in the arts, and it demonstrates that quantum power is something everyone can appreciate and enjoy."

Quantum teleportation is the ability instantaneously to transmit quantum information over vast distances, with scientists having previously used it to send information from Earth to an orbiting satellite over 870 miles away.

In the current study, Dr Kirke describes how he used a system called MIq (Multi-Agent Interactive qgMuse), in which an IBM quantum computer executes a methodology called Grover's Algorithm.

Discovered by Lov Grover at Bell Labs in 1996, it was the second main quantum algorithm (after Shor's algorithm) and gave a huge advantage over traditional computing.

In this instance, it allows the dynamic solving of musical logical rules which, for example, could prevent dissonance or keep to instead of common time.

It is significantly faster than any classical computer algorithm, and Dr Kirke said that speed was essential because there is no way to transmit quantum information other than through teleportation.

The result was that when played the theme from Game of Thrones on the piano, the computer a 14-qubit machine housed at IBM in Melbourne rapidly generated accompanying music that was transmitted back in response.

Dr Kirke, who in 2016 staged the first-ever duet between a live singer and a quantum supercomputer, said: "At the moment there are limits to how complex a real-time computer jamming system can be. The number of musical rules that a human improviser knows intuitively would simply take a computer too long to solve to real-time music. Shortcuts have been invented to speed up this process in rule-based AI music, but using the quantum computer speed-up has not been tried before.

"So, while teleportation cannot move information faster than the speed of light, if remote collaborators want to connect up their quantum computers (which they are using to increase the speed of their musical AIs), it is 100% necessary. Quantum information simply cannot be transmitted using normal digital transmission systems."

More:

- Making science fiction a reality: Teleportation helps to create live musical performance - Design Products & Applications

Read the Rest...

« Older Entries Newer Entries »



Page 3«..2345..1020..»